4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,970 | 153,001 | 90,989 | 243,743 | 259,865 |
| Marketable Securities | 160,183 | 94,776 | 70,686 | N/A | N/A |
| Receivables | N/A | 47 | 791 | 1,218 | 965 |
| TOTAL | $243,047 | $256,280 | $165,733 | $248,752 | $264,501 |
| Non-Current Assets | |||||
| PPE Net | 18,456 | 14,391 | 8,789 | 5,580 | 5,011 |
| Investments And Advances | 48,362 | 67,652 | 65,494 | 0 | 0 |
| Other Non-Current Assets | 15,061 | 15,164 | 602 | 602 | 602 |
| TOTAL | $81,879 | $97,207 | $74,885 | $6,182 | $5,613 |
| Total Assets | $324,926 | $353,487 | $240,618 | $254,934 | $270,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,681 | 4,764 | 3,713 | 1,962 | 1,284 |
| Accrued Expenses | 5,264 | 7,744 | 5,932 | 4,892 | 5,545 |
| TOTAL | $12,091 | $16,338 | $11,373 | $9,870 | $13,916 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,109 | 2,599 | 1,728 | 3,016 | 7,087 |
| Other Non-Current Liabilities | 15,018 | 15,551 | 2,101 | 2,076 | 2,077 |
| TOTAL | $16,779 | $18,042 | $5,111 | $4,418 | $13,767 |
| Total Liabilities | $28,870 | $34,380 | $16,484 | $14,288 | $27,683 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,300 | 32,238 | 32,139 | 26,988 | 26,746 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -233,334 | -206,996 | -181,913 | -159,674 | -152,085 |
| Other shareholders' equity | -1,421 | -423 | -195 | 0 | 0 |
| TOTAL | $296,056 | $319,107 | $224,134 | $240,646 | $242,431 |
| Total Liabilities And Equity | $324,926 | $353,487 | $240,618 | $254,934 | $270,114 |